Association Between Arsenic Exposure from Drinking Water and Proteinuria: Results from the Health Effects of Arsenic Longitudinal Study

Overview

Journal Int J Epidemiol

Specialty Public Health

Date 2011 Feb 24

PMID 21343184

Citations 21

Authors

Yu Chen

Faruque Parvez

Mengling Liu

Gene R Pesola

Mary V Gamble

Vesna Slavkovich

Tariqul Islam

Alauddin Ahmed

Rabiul Hasan

Joseph H Graziano

Habibul Ahsan

Affiliations

Soon will be listed here.

Abstract

Background: Proteinuria has been recognized as a marker for an increased risk of chronic renal disease. It is unclear whether arsenic (As) exposure from drinking water is associated with proteinuria.

Methods: We evaluated the association between As exposure from drinking water and proteinuria in 11,122 participants in the Health Effects of Arsenic Longitudinal Study (HEALS). Proteinuria was detected by urinary dipstick tests at baseline and at 2-year intervals. As exposure variables included baseline well As and changes in urinary As during follow-up modelled as time-dependent variables in the analyses.

Results: At baseline, well As was positively related to prevalence of proteinuria; prevalence odds ratios (PORs) for proteinuria in increasing quintiles of well As (≤ 7, 8-39, 40-91, 92-179 and 180-864 µg/l) were 1.00 (ref), POR 0.99 [95% confidence interval (CI) 0.77-1.27], POR 1.23 (95% CI 0.97-1.57), POR 1.50 (95% CI 1.18-1.89) and POR 1.59 (95% CI 1.26-2.00) (P for trend <0.01). Hazard ratios for incidence of proteinuria were POR 0.83 (95% CI 0.67-1.03) and POR 0.91 (95% CI 0.74-1.12) for participants with a decreasing level of >70 and 17-70 µg/l in urinary As over time, respectively, and were POR 1.17 (95% CI 0.97-1.42) and POR 1.42 (95% CI 1.16-1.73) for participants with an increasing level of 16-68 and >68 µg/l in urinary As over time, respectively, compared with the group with relatively little changes in urinary As as the reference group (urinary As -16 to 15 µg/l).

Conclusion: The findings suggest that there are adverse effects of As exposure on the risk of proteinuria and the effects are modifiable by recent changes in As exposure.

Citing Articles

Longitudinal leucocyte DNA methylation changes in Mesoamerican nephropathy.

Oomatia A, Chervova O, Al-Rashed A, Smpokou E, Ecker S, Pearce N Environ Epigenet. 2025; 11(1):dvaf001.

PMID: 39917055 PMC: 11801219. DOI: 10.1093/eep/dvaf001.

Heavy metals: toxicity and human health effects.

Jomova K, Alomar S, Nepovimova E, Kuca K, Valko M Arch Toxicol. 2024; 99(1):153-209.

PMID: 39567405 PMC: 11742009. DOI: 10.1007/s00204-024-03903-2.

Update of the risk assessment of inorganic arsenic in food.

Schrenk D, Bignami M, Bodin L, Chipman J, Del Mazo J, Grasl-Kraupp B EFSA J. 2024; 22(1):e8488.

PMID: 38239496 PMC: 10794945. DOI: 10.2903/j.efsa.2024.8488.

Revisiting the Role of NAG across the Continuum of Kidney Disease.

Novak R, Salai G, Hrkac S, Vojtusek I, Grgurevic L Bioengineering (Basel). 2023; 10(4).

PMID: 37106631 PMC: 10136202. DOI: 10.3390/bioengineering10040444.

Low- and moderate- levels of arsenic exposure in young adulthood and incidence of chronic kidney disease: Findings from the CARDIA Trace Element Study.

Yang K, Chen C, Brockman J, Shikany J, He K J Trace Elem Med Biol. 2020; 63:126657.

PMID: 33069098 PMC: 7722195. DOI: 10.1016/j.jtemb.2020.126657.

References

Chiou H, HUANG W, Su C, Chang S, Hsu Y, Chen C . Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. Stroke. 1997; 28(9):1717-23. DOI: 10.1161/01.str.28.9.1717. View

Chen Y, van Geen A, Graziano J, Pfaff A, Madajewicz M, Parvez F . Reduction in urinary arsenic levels in response to arsenic mitigation efforts in Araihazar, Bangladesh. Environ Health Perspect. 2007; 115(6):917-23. PMC: 1892113. DOI: 10.1289/ehp.9833. View

Cheng Z, van Geen A, Seddique A, Ahmed K . Limited temporal variability of arsenic concentrations in 20 wells monitored for 3 years in Araihazar, Bangladesh. Environ Sci Technol. 2005; 39(13):4759-66. DOI: 10.1021/es048065f. View

Wang C, Jeng J, Yip P, Chen C, Hsu L, Hsueh Y . Biological gradient between long-term arsenic exposure and carotid atherosclerosis. Circulation. 2002; 105(15):1804-9. DOI: 10.1161/01.cir.0000015862.64816.b2. View

Tseng C, Chong C, Chen C, Tai T . Lipid profile and peripheral vascular disease in arseniasis-hyperendemic villages in Taiwan. Angiology. 1997; 48(4):321-35. DOI: 10.1177/000331979704800405. View

Barr D, Wilder L, Caudill S, Gonzalez A, Needham L, Pirkle J . Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect. 2005; 113(2):192-200. PMC: 1277864. DOI: 10.1289/ehp.7337. View

Lewis D, Southwick J, Rench J, Calderon R . Drinking water arsenic in Utah: A cohort mortality study. Environ Health Perspect. 1999; 107(5):359-65. PMC: 1566417. DOI: 10.1289/ehp.99107359. View

Ahsan H, Chen Y, Kibriya M, Slavkovich V, Parvez F, Jasmine F . Arsenic metabolism, genetic susceptibility, and risk of premalignant skin lesions in Bangladesh. Cancer Epidemiol Biomarkers Prev. 2007; 16(6):1270-8. DOI: 10.1158/1055-9965.EPI-06-0676. View

van Geen A, Ahsan H, Horneman A, Dhar R, Zheng Y, Hussain I . Promotion of well-switching to mitigate the current arsenic crisis in Bangladesh. Bull World Health Organ. 2002; 80(9):732-7. PMC: 2567605. View

10.

Jee S, Boulware L, Guallar E, Suh I, Appel L, Miller 3rd E . Direct, progressive association of cardiovascular risk factors with incident proteinuria: results from the Korea Medical Insurance Corporation (KMIC) study. Arch Intern Med. 2005; 165(19):2299-304. DOI: 10.1001/archinte.165.19.2299. View

11.

Bunderson M, Brooks D, Walker D, Rosenfeld M, Coffin J, Beall H . Arsenic exposure exacerbates atherosclerotic plaque formation and increases nitrotyrosine and leukotriene biosynthesis. Toxicol Appl Pharmacol. 2004; 201(1):32-9. DOI: 10.1016/j.taap.2004.04.008. View

12.

Berrut G, Bouhanick B, Fabbri P, Guilloteau G, Bled F, Le Jeune J . Microalbuminuria as a predictor of a drop in glomerular filtration rate in subjects with non-insulin-dependent diabetes mellitus and hypertension. Clin Nephrol. 1997; 48(2):92-7. View

13.

Esterbauer H, Schaur R, Zollner H . Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med. 1991; 11(1):81-128. DOI: 10.1016/0891-5849(91)90192-6. View

14.

Liao Y, Li W, Chen C, Prineas R, Chen W, Zhang Z . Synergistic effect of polymorphisms of paraoxonase gene cluster and arsenic exposure on electrocardiogram abnormality. Toxicol Appl Pharmacol. 2009; 239(2):178-83. DOI: 10.1016/j.taap.2008.12.017. View

15.

Nixon D, Mussmann G, Eckdahl S, Moyer T . Total arsenic in urine: palladium-persulfate vs nickel as a matrix modifier for graphite furnace atomic absorption spectrophotometry. Clin Chem. 1991; 37(9):1575-9. View

16.

Morales K, Ryan L, Kuo T, Wu M, Chen C . Risk of internal cancers from arsenic in drinking water. Environ Health Perspect. 2000; 108(7):655-61. PMC: 1638195. DOI: 10.1289/ehp.00108655. View

17.

Albert C, Cook N, Gaziano J, Zaharris E, MacFadyen J, Danielson E . Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA. 2008; 299(17):2027-36. PMC: 2684623. DOI: 10.1001/jama.299.17.2027. View

18.

Meliker J, Wahl R, Cameron L, Nriagu J . Arsenic in drinking water and cerebrovascular disease, diabetes mellitus, and kidney disease in Michigan: a standardized mortality ratio analysis. Environ Health. 2007; 6:4. PMC: 1797014. DOI: 10.1186/1476-069X-6-4. View

19.

Chen C, Kuo T, Wu M . Arsenic and cancers. Lancet. 1988; 1(8582):414-5. DOI: 10.1016/s0140-6736(88)91207-x. View

20.

Hall M, Chen Y, Ahsan H, Slavkovich V, van Geen A, Parvez F . Blood arsenic as a biomarker of arsenic exposure: results from a prospective study. Toxicology. 2006; 225(2-3):225-33. DOI: 10.1016/j.tox.2006.06.010. View